Crossmark

Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults

Crossref DOI link: https://doi.org/10.1038/bmt.2015.118

Published Online: 2015-06-01

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Loschi, S

Dufour, C

Oberlin, O

Goma, G

Valteau-Couanet, D

Gaspar, N
License Information

Text and Data Mining valid from 2015-06-01

Version of Record valid from 2015-06-01
More Information

Article History

Received: 14 October 2014

Revised: 25 March 2015

Accepted: 9 April 2015

First Online: 1 June 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below